|
JAMA Neurology |
Popeye Sign in Hereditary Transthyretin Amyloidosis |
1 |
Yes |
7/3/2024 |
|
JAMA Neurology |
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration |
1 |
Yes |
7/8/2024 |
|
JAMA Neurology |
Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures |
1 |
Yes |
7/8/2024 |
|
JAMA Neurology |
Facial Numbness, Dysarthria, Muscle Atrophy, and Weakness in a Young Patient |
1 |
Yes |
7/12/2024 |
|
JAMA Neurology |
Multiple Facial Ulcers Following a Stroke |
1 |
Yes |
7/19/2024 |
|
JAMA Neurology |
Direct to Angiography vs Repeated Imaging Approaches in Transferred Patients Undergoing Endovascular Thrombectomy |
1 |
Yes |
8/12/2024 |
|
JAMA Neurology |
Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study |
1 |
Yes |
8/12/2024 |
|
JAMA Neurology |
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis |
1 |
Yes |
8/14/2024 |
|
JAMA Neurology |
Epilepsy in a Patient With Brain Herniation Into the Arachnoid Granulation |
1 |
Yes |
9/5/2024 |
|
JAMA Neurology |
Association of Field Position and Career Length With Risk of Neurodegenerative Disease in Male Former Professional Soccer Players |
1 |
Yes |
9/9/2024 |
|
JAMA Neurology |
Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury - A TRACK-TBI Study With External Validation in CENTER-TBI |
1 |
Yes |
9/9/2024 |
|
JAMA Neurology |
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2 |
1 |
Yes |
9/17/2024 |
|
JAMA Neurology |
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis - A Systematic Review |
1 |
Yes |
10/2/2024 |
|
JAMA Neurology |
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss |
1 |
Yes |
10/2/2024 |
|
JAMA Neurology |
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis |
1 |
Yes |
10/7/2024 |
|
JAMA Neurology |
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 VaccineInduced Immune Thrombotic Thrombocytopenia |
1 |
Yes |
10/7/2024 |
|
JAMA Neurology |
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab |
1 |
Yes |
10/7/2024 |
|
JAMA Neurology |
Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture |
1 |
Yes |
10/9/2024 |
|
JAMA Neurology |
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage - Extended Follow-up of the RESTART Randomized Clinical Trial |
1 |
Yes |
10/14/2024 |
|
JAMA Neurology |
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis - Data From 2 Different National Strategies |
1 |
Yes |
10/14/2024 |
